Clinical valve thrombosis in transcatheter aortic valve associated with simultaneous embolic stroke and splenic infarction: A case report

Authors

  • Julieta Danira Morales-Portano Cardiology department. "20 de Noviembre" National Medical Center. ISSSTE. Mexico City. Mexico https://orcid.org/0000-0003-3953-6833
  • Salvador Guzmán Castro Departamento de Cardiología. Centro Médico Nacional «20 de Noviembre», ISSSTE. Ciudad de México. México. https://orcid.org/0000-0001-7148-8056
  • Elias Andrade-Cuellar Cardiology department. "20 de Noviembre" National Medical Center. ISSSTE. Mexico City. Mexico https://orcid.org/0000-0002-0753-457X
  • Luz Dinora Sandoval-Castillo Cardiology department. "20 de Noviembre" National Medical Center. ISSSTE. Mexico City. Mexico https://orcid.org/0000-0002-7049-5200
  • Jesús Ricardo Pérez-Castellanos Cardiology department. "20 de Noviembre" National Medical Center. ISSSTE. Mexico City. Mexico https://orcid.org/0000-0003-0822-4925

DOI:

https://doi.org/10.37615/retic.v7n1a11

Keywords:

thrombosis, transcatheter valve, splenic infarction

Abstract

An 83-year-old woman with progressive dyspnea of 1 month of evolution, in NYHA functional class III. Physical examination revealed a crescendo-decrescendo ejective aortic murmur, second noise erased and left supraclavicular irradiation. A diagnosis of severe aortic stenosis was made, and he underwent transcatheter aortic valve replacement with a Sapiens 3 No. 29 valve. At 18 months, she presented deterioration of functional class; fulfilling echocardiographic and tomographic criteria for valve thrombosis. Highlight the use of multiimaging in the diagnosis of this common complication of aortic valve implants

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Rheude T, Pellegrini C, Stortecky S, Marwan M, Xhepa E, Ammon F, et al. Meta-Analysis of Bioprosthetic Valve Thrombosis After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2021 Jan 1;138:92–9. doi: https://doi.org/10.1016/j.amjcard.2020.10.018 DOI: https://doi.org/10.1016/j.amjcard.2020.10.018

Capodanno D, Collet JP, Dangas G, Montalescot G, ten Berg JM, Windecker S, et al. Antithrombotic Therapy After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2021 Aug 9;14(15):1688–703. doi: https://doi.org/10.1016/j.jcin.2021.06.020 DOI: https://doi.org/10.1016/j.jcin.2021.06.020

Otto CM, Nishimura RA, Bonow RO, Carabello BA, rwin JP, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation [Internet]. 2021 Feb 2 [cited 2023 Mar 15];143(5):E35–71. Available from: https://www.ahajournals.org/doi/abs/10.1161/CIR.0000000000000932 DOI: https://doi.org/10.1161/CIR.0000000000000932

Chakravarty T, Søndergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. The Lancet [Internet]. 2017 Jun 17 [cited 2023 Mar 15];389(10087):2383–92. Available from: http://www.thelancet.com/article/S0140673617307572/fulltext DOI: https://doi.org/10.1016/S0140-6736(17)30757-2

Imaeda S, Inohara T, Yoshijima N, Kobari Y, Myojin S, Ryuzaki T, et al. Natural History of Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A 5‐Year Follow‐Up Study. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease [Internet]. 2022 Dec 6 [cited 2023 Mar 14];11(23). doi: https://doi.org/10.1161/JAHA.122.026334 DOI: https://doi.org/10.1161/JAHA.122.026334

Bogyi M, Schernthaner RE, Loewe C, Gager GM, Dizdarevic AM, Kronberger C, et al. Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A Meta-Analysis. JACC Cardiovasc Interv. 2021 Dec 27;14(24):2643–56. doi: https://doi.org/10.1016/j.jcin.2021.09.019 DOI: https://doi.org/10.1016/j.jcin.2021.09.019

Nijenhuis, V. J., Brouwer, J., Delewi, R., Hermanides, R. S., Holvoet, W., Dubois, C. L. F., … ten Berg, J. M. (2020). Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. New England Journal of Medicine, 382(18), 1696–1707. doi: https://doi.org/10.1056/NEJMoa1915152 DOI: https://doi.org/10.1056/NEJMoa1915152

Dangas, G. D., Tijssen, J. G. P., Wöhrle, J., Søndergaard, L., Gilard, M., Möllmann, H., Windecker, S. (2020). A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. New England Journal of Medicine, 382(2), 120–129. doi: https://doi.org/10.1056/NEJMoa1911425 DOI: https://doi.org/10.1056/NEJMoa1911425

Mousa TAM, Mahfouz A, Mohammed N. Antithrombotic Therapy after Transcatheter Aortic Valve Replacement. Heart Views [Internet]. 2022 [cited 2023 Mar 14];23(1):10. doi: https://doi.org/10.4103/heartviews.heartviews_36_22 DOI: https://doi.org/10.4103/heartviews.heartviews_36_22

Published

2024-04-24

How to Cite

1.
Morales-Portano JD, Guzmán Castro S, Andrade-Cuellar E, Sandoval-Castillo LD, Pérez-Castellanos JR. Clinical valve thrombosis in transcatheter aortic valve associated with simultaneous embolic stroke and splenic infarction: A case report. Rev Ecocardiogr Pract Otras Tec Imag Card (RETIC) [Internet]. 2024 Apr. 24 [cited 2024 Jul. 3];7(1):42-6. Available from: https://imagenretic.org/RevEcocarPract/article/view/601